PUBLISHER: IMARC | PRODUCT CODE: 1467578
PUBLISHER: IMARC | PRODUCT CODE: 1467578
The global gastrointestinal stents market size reached US$ 433.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 572.5 Million by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032.
A gastrointestinal stent refers to an artificial tube graft that is inserted in the body to prevent blockages in the gullet, stomach and small intestine. It is an expandable metal or a plastic mesh tube that is placed in an anatomical duct, such as bile ducts, esophagus, bowel or colon, and blockages due to cancerous tissues. It aims to remove the obstruction and reduce the pressure caused by inflammation. Some of the most common types of gastrointestinal stents include biliary, colonic, duodenal, esophageal and pancreatic stents.
The rising prevalence of colorectal cancer across the globe is one of the key factors driving the growth of the market. Furthermore, an increasing geriatric population suffering from gastrointestinal diseases, such as bowel ailments, diverticulosis and gastrointestinal malignancies, is also providing a boost to the market growth. Additionally, the growing preference for minimally invasive (MI) surgical procedures, along with the rising health consciousness among the masses, is creating a significant impact on the market. In comparison to the traditional open surgery procedures, gastrointestinal stenting involves low risk of infections, minimal loss of blood and quick recuperation period. Moreover, various technological advancements, including the development of bio-absorbable and nitinol material-based stents offering a high degree of flexibility and kink-resistance, is acting as another growth-inducing factor. Other factors, including significant growth in the healthcare infrastructure, the implementation of favourable government policies and extensive research and development (R&D) activities, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global gastrointestinal stents market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, technology type, material and end user.
Biliary Stents
Duodenal Stents
Colonic Stents
Pancreatic Stents
Esophageal Stents
Anti-Migratory Stents
Drug-Eluting Stents
Radioactive Stents
Anti-Reflux Stents
Shape-Modified Stents
Others
Plastic Stents
Self-Expanding Metal Stents
Stainless Steel Stents
Nitinol Stents
Others
Covered Self-Expandable Metallic Stents
Biodegradable or Drug Eluting Stents
Hospitals
Specialty Clinics
Ambulatory Surgical Centres
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined with some of the key players being Becton, Dickinson and Company, Boston Scientific Corporation, Cantel Medical Corporation, Conmed Corporation, Cook Group Incorporated, ELLA-CS, S.R.O., Hobbs Medical Inc., Merit Medical Systems Inc., Olympus Corporation, Taewoong Medical Co. Ltd., etc.